Claudin-2 expression increases tumorigenicity of colon cancer cells: Role of epidermal growth factor receptor activation

Oncogene

Volumn 30, Issue 29, 2011, Pages 3234-3247

  Dhawan, P ^a,b   Ahmad, R ^a   Chaturvedi, R ^a   Smith, J J ^a   Midha, R ^a   Mittal, M K ^a   Krishnan, M ^a   Chen, X ^a   Eschrich, S ^c   Yeatman, T J ^c   Harris, R C ^a   Washington, M K ^a   Wilson, K T ^a,b   Beauchamp, R D ^a,b   Singh, A B ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

claudin; colon cancer; EGFR; proliferation; tight junction

Indexed keywords

CLAUDIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENTERITIS; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR GROWTH;

ANIMALS; CACO-2 CELLS; CELL DIVISION; COLONIC NEOPLASMS; EPIDERMAL GROWTH FACTOR; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INFLAMMATORY BOWEL DISEASES; MEMBRANE PROTEINS; MICE; MICE, NUDE; PROTEIN KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

MUS;

EID: 79960706000     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.43     Document Type: Article

References (54)

1. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Soderholm JD, Zeitz M et al. (2009). Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44: 1226-1235.
2. Angelow S, Schneeberger EE, Yu AS. (2007). Claudin-8 expression in renal epithelial cells augments the paracellular barrier by replacing endogenous claudin-2. J Membr Biol 215: 147-159. (Pubitemid 47282681)
3. Ansfield F, Klotz J, Nealon T, Ramirez G, Minton J, Hill G et al. (1977). A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report. Cancer 39: 34-40. (Pubitemid 8028974)
4. Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, Baselga J. (1997). PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 3: 2099-2106. (Pubitemid 27505138)
5. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V et al. (2010). Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci USA 107: 2628-2633.
6. Buzza MS, Netzel-Arnett S, Shea-Donohue T, Zhao A, Lin CY, List K et al. (2010). Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci USA 107: 4200-4205.
7. Cereijido M, Contreras RG, Shoshani L. (2004). Cell adhesion, polarity, and epithelia in the dawn of metazoans. Physiol Rev 84: 1229-1262. (Pubitemid 39302635)
8. Cutler NS, Graves-Deal R, LaFleur BJ, Gao Z, Boman BM, Whitehead RH et al. (2003). Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res 63: 1748-1751. (Pubitemid 36460831)
9. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C et al. (1999). Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 94: 2956-2960. (Pubitemid 29482764)
10. Dahlhoff M, Horst D, Gerhard M, Kolligs FT, Wolf E, Schneider MR. (2008). Betacellulin stimulates growth of the mouse intestinal epithelium and increases adenoma multiplicity in Apc+/Min mice. FEBS Lett. 582: 2911-2915.
11. Davies RJ, Joseph R, Asbun H, Sedwitz M. (1989). Detection of the cancer-prone colon, using transepithelial impedance analysis. Arch Surg 124: 480-484. (Pubitemid 19106443)
12. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C et al. (2005). Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776. (Pubitemid 40979715)
13. Eaden JA, Abrams KR, Mayberry JF. (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535. (Pubitemid 32234798)
14. Escaffit F, Boudreau F, Beaulieu JF. (2005). Differential expression of claudin-2 along the human intestine: implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J Cell Physiol 203: 15-26. (Pubitemid 40328168)
15. Flores-Benitez D, Ruiz-Cabrera A, Flores-Maldonado C, Shoshani L, Cereijido M, Contreras RG. (2007). Control of tight junctional sealing: role of epidermal growth factor. Am J Physiol Renal Physiol 292: F828-F836. (Pubitemid 46220552)
16. Furuse M, Furuse K, Sasaki H, Tsukita S. (2001). Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into madin-darby canine kidney I cells. J Cell Biol 153: 263-272. (Pubitemid 34280213)
17. Furuse M, Tsukita S. (2006). Claudins in occluding junctions of humans and flies. Trends Cell Biol. 16: 181-188.
18. Guillemot L, Citi S. (2006). Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA. Mol Biol Cell 17: 3569-3577. (Pubitemid 44156449)
19. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B et al. (2005). Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564. (Pubitemid 41096643)
20. Helmrath MA, Shin CE, Erwin CR, Warner BW. (1998). The EGF/EGF-receptor axis modulates enterocyte apoptosis during intestinal adaptation. J Surg Res 77: 17-22. (Pubitemid 28364175)
21. Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. (2006). Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 6: 581-588.
22. Kim EC, Zhu Y, Andersen V, Sciaky D, Cao HJ, Meekins H et al. (1998). Cytokine-mediated PGE2 expression in human colonic fibroblasts. Am J Physiol Cell Physiol 275: C988-C994.
23. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T et al. (2007). Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 27: 3729-3734. (Pubitemid 47598437)
24. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. (2000). Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001-1011. (Pubitemid 30346975)
25. Krishnan M, Singh AB, Smith JJ, Sharma A, Chen X, Eschrich S et al. (2010). HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. Oncogene 29: 305-312.
26. Lal-Nag M, Morin P. (2009). The claudins. Genome Biol 10: 235.
27. Luetteke NC, Phillips HK, Qiu TH, Copeland NG, Earp HS, Jenkins NA et al. (1994). The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev 8: 399-413. (Pubitemid 24071181)
28. Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B et al. (2009). TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res 336: 67-77.
29. Mankertz J, Hillenbrand B, Tavalali S, Huber O, Fromm M, Schulzke JD. (2004). Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun 314: 1001-1007. (Pubitemid 38142383)
30. Mima S, Takehara M, Takada H, Nishimura T, Hoshino T, Mizushima T. (2008). NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells. Carcinogenesis 29: 1994-2000.
31. Mullin JM. (2004). Epithelial barriers, compartmentation, and cancer. Sci STKE 2004: pe2.
32. Mullin JM, McGinn MT. (1987). The phorbol ester, TPA, increases transepithelial epidermal growth factor flux. FEBS Lett. 221: 359-364. (Pubitemid 17127598)
33. Mullin JM, O'Brien TG. (1986). Effects of tumor promoters on LLC-PK1 renal epithelial tight junctions and transepithelial fluxes. Am J Physiol Cell Physiol 251: C597-C602.
34. Mullin JM, Snock KV, Shurina RD, Noe J, George K, Misner L et al. (1992). Effects of acute vs. chronic phorbol ester exposure on transepithelial permeability and epithelial morphology. J Cell Physiol 152: 35-47.
35. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. (2002). Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8: 289-293. (Pubitemid 34250108)
36. Peter Y, Comellas A, Levantini E, Ingenito EP, Shapiro SD. (2009). Epidermal growth factor receptor and claudin-2 participate in A549 permeability and remodeling: implications for non-small cell lung cancer tumor colonization. Mol Carcinog 48: 488-497.
37. Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT et al. (2005). Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 85: 1139-1162. (Pubitemid 43073987)
38. Rego RL, Foster NR, Smyrk TC, Le M, O'Connell MJ, Sargent DJ et al. (2009). Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br J Cancer 102: 165-172.
39. Reyes JL, Lamas M, Martin D, del Carmen Namorado M, Islas S, Luna J et al. (2002). The renal segmental distribution of claudins changes with development. Kidney Int 62: 476-487. (Pubitemid 34779758)
40. Ridyard AE, Brown JK, Rhind SM, Else RW, Simpson JW, Miller HR. (2007). Apical junction complex protein expression in the canine colon: differential expression of claudin-2 in the colonic mucosa in dogs with idiopathic colitis. J Histochem Cytochem 55: 1049-1058. (Pubitemid 47427651)
41. Roberts RB, Min L, Washington MK, Olsen SJ, Settle SH, Coffey RJ et al. (2002). Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci USA 99: 1521-1526. (Pubitemid 34136525)
42. Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC. (2002). Cloning of the human claudin-2 50-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1a. J Biol Chem 277: 21361-21370. (Pubitemid 34952276)
43. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD et al. (2007). Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Cancer Res 67: 1571-1579. (Pubitemid 46383381)
44. Singh AB, Harris RC. (2004). Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells. J Biol Chem 279: 3543-3552. (Pubitemid 38140594)
45. Singh AB, Harris RC. (2005). Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal. 17: 1183-1193. (Pubitemid 40984037)
46. Singh AB, Sugimoto K, Dhawan P, Harris RC. (2007). Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am J Physiol Cell Physiol 293: C1660-C1668. (Pubitemid 350085633)
47. Singh AB, Sugimoto K, Harris RC. (2007). Juxtacrine activation of epidermal growth factor (EGF) receptor by membrane-anchored heparin-binding EGF-like growth factor protects epithelial cells from anoikis while maintaining an epithelial phenotype. J Biol Chem 282: 32890-32901. (Pubitemid 350159321)
48. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. (1999). Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20: 1425-1432.
49. Takehara M, Nishimura T, Mima S, Hoshino T, Mizushima T. 2009. Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull 32: 825-831.
50. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. (2008). Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 88: 1110-1120.
51. Yabana T, Arimura Y, Tanaka H, Goto A, Hosokawa M, Nagaishi K et al. (2009). Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity. J Pathol 218: 350-359.
52. Yamaoka T, Yan F, Cao H, Hobbs SS, Dise RS, Tong W et al. (2008). Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis. Proc Natl Acad Sci USA 105: 11772-11777.
53. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U et al. (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72. (Pubitemid 46044890)
54. Zhu Y, Hua P, Lance P. (2003). Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains. Cancer Res 63: 522-526. (Pubitemid 36152516)